Tower Research Capital LLC TRC Has $3.06 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (2024)

Tower Research Capital LLC TRC increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 139.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 117,291 shares of the pharmacy operator's stock after acquiring an additional 68,242 shares during the quarter. Tower Research Capital LLC TRC's holdings in Walgreens Boots Alliance were worth $3,062,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Capital World Investors raised its holdings in shares of Walgreens Boots Alliance by 29.1% during the fourth quarter. Capital World Investors now owns 18,448,648 shares of the pharmacy operator's stock valued at $481,694,000 after acquiring an additional 4,163,317 shares during the period. Capital International Sarl grew its position in Walgreens Boots Alliance by 9.2% during the fourth quarter. Capital International Sarl now owns 179,711 shares of the pharmacy operator's stock valued at $4,692,000 after purchasing an additional 15,124 shares in the last quarter. Copperwynd Financial LLC grew its position in Walgreens Boots Alliance by 6.6% during the fourth quarter. Copperwynd Financial LLC now owns 15,171 shares of the pharmacy operator's stock valued at $396,000 after purchasing an additional 936 shares in the last quarter. Rafferty Asset Management LLC grew its position in Walgreens Boots Alliance by 13.5% during the fourth quarter. Rafferty Asset Management LLC now owns 510,872 shares of the pharmacy operator's stock valued at $13,339,000 after purchasing an additional 60,872 shares in the last quarter. Finally, NEOS Investment Management LLC grew its position in Walgreens Boots Alliance by 2.7% during the fourth quarter. NEOS Investment Management LLC now owns 42,879 shares of the pharmacy operator's stock valued at $1,120,000 after purchasing an additional 1,118 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Insider Activity at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the company's stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari acquired 3,000 shares of the company's stock in a transaction dated Thursday, April 11th. The stock was bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Manmohan Mahajan acquired 6,000 shares of the company's stock in a transaction dated Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently commented on WBA shares. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a research report on Wednesday, April 3rd. Leerink Partnrs reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Evercore ISI decreased their target price on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an "in-line" rating for the company in a research report on Monday, June 3rd. UBS Group decreased their target price on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating for the company in a research report on Wednesday, April 3rd. Finally, Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an "underweight" rating for the company in a research report on Friday, May 31st. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance has a consensus rating of "Hold" and an average price target of $23.57.

Read Our Latest Report on WBA

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock traded down $0.02 on Friday, reaching $15.84. The stock had a trading volume of 8,431,777 shares, compared to its average volume of 12,615,298. The stock has a market cap of $13.67 billion, a P/E ratio of -2.26, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78. Walgreens Boots Alliance, Inc. has a fifty-two week low of $14.62 and a fifty-two week high of $32.89. The business's 50-day moving average price is $17.43 and its two-hundred day moving average price is $20.79. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analysts' expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.16 EPS. On average, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 6.31%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance's payout ratio is currently -14.29%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

• Five stocks we like better than Walgreens Boots Alliance
• Using the MarketBeat Stock Split Calculator
• MarketBeat Week in Review – 6/3 - 6/7
• Why Invest in 5G? How to Invest in 5G Stocks
• Geron Corporation: FDA Approval Fuels Stock Price Surge
• Why is the Ex-Dividend Date Significant to Investors?
• Intel's Secret Plan for a Double-Digit Stock Rally Revealed

Should you invest $1,000 in Walgreens Boots Alliance right now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here